Endothelial cell (EC) dysfunction has been reported in cystic fibrosis (CF) patients. Thus, the availability of CF EC is paramount to uncover mechanisms of endothelial dysfunction in CF. Using collagenase digestion, we isolated cells from small fragments of pulmonary artery dissected from non-CF lobes or explanted CF lungs. These cells were a heterogeneous mixture, containing variable percentages of EC. To obtain virtually pure pulmonary artery endothelial cells (PAEC), we developed an easy, inexpensive, and reliable method, based on the differential adhesion time of pulmonary artery cells collected after collagenase digestion. With this method, we obtained up to 95% pure non-CF and CF-PAEC. Moreover, we also succeed at immortalizing both PAEC and CF-PAEC, which remained viable and with unchanged phenotype and proliferation rate over the 30th passage. These cells recapitulated cystic fibrosis transmembrane conductance regulator expression and functions of the parental cells. Thus, we isolated for the first time endothelial cells from CF patients, providing a valuable tool to define the emerging role of EC in CF lung and vascular disease.
The vascular endothelium is a metabolically active compartment that regulates a number of key homeostatic processes, including hemostasis and blood coagulation, the vascular tone and the immune-inflammatory response. 1,2 A dysfunctional endothelium is the hallmark of a variety of pathologic conditions, being atherosclerosis and thrombosis the best known. 2 However, endothelial dysfunction has also a profound impact on the inflammatory response and its resolution, as it promotes leukocyte recruitment and consequent tissue damage. 3 Cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene on chromosome 7, 4 being phenyl-alanine 508 deletion (F508del) present in~70% of CF patients. A dysfunctional CFTR alters profoundly Cl − and HCO3 − secretion, resulting in the deprivation of the periciliary fluid volume in the airways, with impairment of the mucociliary clearance and aberrant infection and neutrophilic inflammation that lead to respiratory insufficiency and death. 5 Although the respiratory epithelium is primarily affected by CFTR dysfunction, the mechanisms of the aberrant, uncontrolled lung inflammation in CF are incompletely known. The observation that CFTR is expressed and biologically active in a wide spectrum of cells, including platelets 6 and leukocytes, 7, 8 has opened new perspective for the definition of the mechanisms underlying CF lung disease.
EC also express CFTR. 9 We have previously documented that CF patients display peripheral signs of endothelial perturbation, which correlates with loss in respiratory function. 10 Moreover, CFTR dysfunction is associated with a variety of morphological and functional alterations in endothelial cells (Totani et al, unpublished data). Along these lines, changes in barrier function have been recently reported in endothelial cells with a dysfunctional CFTR. 11 Main aim of this study was to develop a simple, inexpensive, and reliable methodology to obtain virtually pure and long-term maintained EC from CF patients. This, as first step to develop research aimed at elucidating the pathobiology of CFTR in EC and the involvement of EC in CF inflammation and vascular pathophysiology.
MATERIALS AND METHODS Isolation and Standard Culture Conditions of Pulmonary Artery Cells
Pulmonary arteries (PA) were excised from explanted CF lungs or from non-CF lungs during lobectomy. All donors signed an informed consent form. After careful removal of fat and connective tissue, segmental branches of the PA were cut into 2-cm pieces, whereas subsegmental branches were cut into 3-4 cm pieces. Fragments were stored in phosphatebuffered saline (PBS) containing linezolid (250 μg/ml)+colis-tin (50 U/ml)+cotrimoxazole (25 μg/ml)+amphotericin B (25 μg/ml) (LCCA). Within 20 h from surgery, arteries were rinsed three times with 0.9% saline containing penicillin/ streptomycin (P/S) (1%) and amphotericin B (25 μg/ml) to remove blood cells. Arteries were then incubated (20 min, 37°C, 5% CO 2 ) with 2 mg/ml type II collagenase (Worthington Biochem, Lakewood, NJ, USA) diluted with calcium and magnesium-free PBS. Immediately after the incubation, arteries were moved into a Petri dish (100 mm) containing endothelial cell culture medium (50% vol/vol DMEM-M199 medium, supplemented with 10% FBS, 1% L-glutamine, 1% penicillin/streptomycin, 1% ECGF, 1% heparin), massaged with a spatula followed by gentle shaking. Cells were collected by centrifugation (330 g for 7 min at room temperature), seeded on fibronectin (1 mg/cm 2 )-coated plates 12 and maintained in the aforementioned culture medium supplemented with LCCA, whose concentration was halved every 2 days until zero, when only the P/S standard concentration was maintained.
Culture Condition during Selection
During selection, cells were maintained with 50% vol/vol DMEM-medium 199 supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 micro/ml streptomycin, and 1% glutamine. After the explant, cells (1 × 10 6 ) were seeded in two 100 mm gelatin-coated dishes. At confluence, cells from both dishes were detached with trypsin and seeded in a new plate. In this phase, 10 min after seeding, the majority of cells remained in the supernatant, while a small number of cells (∼8-10%) was already adherent. At this time point, the supernatant was removed from one of the plates and replaced with fresh medium, whereas the second plate was left untouched. This adherence time-based selection procedure was repeated at each passage until a virtually pure population of pulmonary artery endothelial cells was obtained. For each selection step, images were taken using an optical microscope.
Immunophenotyping Cells (5 × 10 5 /sample) were immunophenotyped by flow cytometry as previously reported. 13 Briefly, samples were centrifuged (400 g, 10 min at room temperature) and washed with 2 ml of stain buffer with bovine serum albumin (Becton Dickinson Biosciences -BD Biosciences, San Jose, CA, USA). For EC identification, surface staining was carried out by adding to the pellet 10 μl fluorescein isothiocyanate (FITC)-conjugated CD31 (BD Biosciences, clone WM59) and 10 μl R-phycoerythrin (PE)-conjugated CD146 (BD Biosciences, clone P1H12). Isotype-matched antibodies were used as negative controls. Samples were incubated for 30 min at 4°C, washed with 2 ml stain buffer with BSA (BD Biosciences) and suspended with 0.5 ml FACSFlow (BD Biosciences). Flow cytometric analysis was carried out by recording 2 × 10 4 events/sample on a FACSCanto II cytometer (BD Biosciences). The following antibodies were used to determine the phenotype of non-EC contained in the mixed population collected from pulmonary artery: CD14 FITC from Miltenyi Biotec, Calderara di Reno (BO), Italy (3 μl); CD44 FITC from BD (3 μl); CD13 FITC from Ancell Corporation, Bayport, MN, USA (1 μl); CD105 FITC from Ancell (1 μl); CD166 FITC from Ancell (1 μl); HLAABC Alexa 488 from BD (10 μl); CD29 PE from Ancell (1 μl); EPCAM PE Cy5.5 from BD Biosciences (10 μl); and CD73 PE from BD Bioscience (5 μl). Antibodies were titrated under assay conditions, in order to obtain optimal dilutions. Instrument performances and data reproducibility were maintained and checked by using the Cytometer Setup and Tracking Module (BD Biosciences). Gates were assessed on the basis of unstained and isotype controls. Compensation was calculated by running CompBeads (BD Biosciences). Data were analyzed using the FACSDiva v 6.1.3 (BD Biosciences) software.
Confocal Microscopy
Cells (2 × 10 4 ) were seeded on glass coverslips pre-coated with 1.5% gelatin and fixed, after 24 h, with 4% paraformaldehyde. Cells were permeabilized with 0.5% saponin and stained overnight at 4°C with primary anti VWF (MA5-14029, Thermo Fisher Scientific, Waltham MA, USA, 1:100 dilution) and anti CD31 (M0823, Dako, 1:25 dilution) antibodies, or 1 h at room temperature with an anti-CFTR antibody (MAB25031, clone 24-1, R&D Systems, Minneapolis, MN, USA, 1:25 dilution), followed by secondary goat anti-mouse IgG conjugated with Alexa Fluor 488 (1 h at 4°C). Cells were incubated with DRAQ-5 together with the secondary antibody for nuclear staining. High definition images were acquired by a LSM-510 META (Carl Zeiss, Jena, Germany) confocal microscope.
Matrigel Assay
A tube formation assay was performed as functional readout of the endothelial phenotype. 14 To this end, matrigel (BD Biosciences) was aliquoted on a 12-well tissue culture plate and allowed to solidify for 1 h at 37°C. Cells (10 5 ) were seeded in 200 μl culture medium w/o serum. Wells were observed under a contrast phase microscope and images taken at 3, 6, and 8 h after seeding. Replicates were performed for each assay condition.
Immortalization of PAEC and CF-PAEC
MuLV retroviral particles were obtained by co-transfection of HEK-293T with plasmids coding for MuLV gag and pol (pUMVC, gift from Bob Weinberg, Addgene plasmid #8449), envelope proteins (pCMV-VSV-G, gift from Bob Weinberg, Addgene plasmid #8454), 15 and pBABE-puro-SV40 LT (gift from Thomas Roberts, Addgene plasmid #13970) 16 modified Scott Dessain and Hua-yin Yu, Weinberg Lab protocol (https://www.addgene.org/static/data/84/61/162606cc-af64-11e0-90fe-003048dd6500.pdf). Cells were infected with retroviral particles in the presence of 5 μg/ml Polybrene (Sigma-Aldrich) and selected with Puromycin (1.5 μg/ml) (InvivoGen). Puromycin-resistant non-CF and CF-PAEC were stained with a FITC-conjugated anti-CD31 antibody (BD Biosciences, clone WM59), as reported above, under sterile conditions. CD31 + cells were sorted using a FACSAria III cell sorter, BD, 100 μm nozzle. 
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Statistical Analysis
Statistical significance was assessed using one-way ANOVA with Bonferroni's post hoc test. P-values o0.05 were considered as statistically significant.
RESULTS
PAEC Enrichment during the Selection Procedure
Pulmonary artery explants contained a mixed cell population with different shapes, mainly fibroblast-like and, at a lower extent, reminiscent of endothelial morphology. 17 These cells were immunophenotyped using several markers (Figure 1 ). 
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Cells isolated from three different donors consistently stained positive for CD44, CD13, CD73, CD105, CD166, HLA-ABC, and CD29, whereas they resulted negative for the monocyte/ macrophage marker CD14, as well as for epithelial EpCAM (Figure 1 ). These populations clearly showed a different adhesion time to gelatin-coated dishes, being cells with the endothelial-like morphology faster to adhere (Figure 2 ). Fast-adhering cells stained positive for both CD31 and CD146, two known endothelial antigens analyzed by flow cytometry 18, 19 (Figures  2b-e) . The percentage of these cells within the explants from two non-CF donors was variable, ranging from 74.2 (Figure 2b ) to 16.9% (Figure 2d ). These percentages increased to 96 (Figure 2c ) and 80.2% (Figure 2e) , respectively, after two and three selection steps. These results indicate that PAEC can be separated from mixed cell cultures based on their adhesion time.
CF-PAEC Isolation and Purification
Since CF-PAEC are of wide interest to understand mechanisms of inflammation and vascular complications in CF, 20, 21 we applied the selection procedure to cells isolated from a lung explanted from a CF patient carrying the genotype G542X/1717-1G-4A genotype. Changes in morphology of the overall cell population during selection is illustrated in Figure 3a , whereas von Willebrand Factor (vWF) and CD31 staining, assessed by confocal microscopy, is shown in Figure 3b . It is evident that during selection, the percentage of cells characterized by typical endothelial morphology (arrows) increased progressively (Figure 3a) . Consistent with this, only few cells within the initial pool (before selection) stained positive for vWF or CD31 (Figure 3b, left panel) , while after the third selection step, almost the whole cell population expressed both antigens (Figure 3b, right panel) . We obtained comparable results (~94% CD146 + /CD31 + ) with surgical specimens collected from another CF patient carrying the F508del/F508del genotype (results not shown).
To further characterize the enrichment of the endothelial compartment during the selection process, CF cells before (step 0) and after three selection passages (step 1, step 2 and step 3, respectively) were analyzed by flow cytometry. As shown in Figure 4a EC phenotype (CD146 + /CD31 + ). Cells subjected to selection (right dot plots) displayed a significant increase in the CD146 + /CD31 + population from 18 to 89%. Data from triplicates are reported in Figure 4b . On the contrary, the percentage of CD146 + /CD31 + cells did not change significantly in non-selected cells (Figure 4a, left plots) . Notably, the CD146 + /CD31 − cell population decreased during the selection procedure in both selected and non-selected samples, while CD146 − /CD31 − cells dramatically decreased from 34.8 to 3.8% after selection (Figure 4a, right plots) .
Tube Formation on Matrigel
The ability of selected and non-selected cells to form tubular structures on matrigel was also assessed. Notably, as early as 3 h after seeding, selected CF cells (Figure 5a ) showed more evident ability to form tubular structures on matrigel as compared to not-selected cells (Figure 5b ). These differences, which were also evident 6 and 8 h after seeding, clearly indicate that the selected population was enriched in PAEC.
Together with data in Figures 3 and 4 , these results indicate that by using a simple procedure is possible to obtain virtually pure CF-PAEC populations.
PAEC and CF-PAEC Immortalization
Because EC in culture have a very limited life span, due to early replicative senescence, we undertook the task to immortalize PAEC and CF-PAEC carrying the F508del/ F508del genotype. To this end, we infected cells with SV40 large T antigen and selected puromycin-resistant cells. SV40 gene expression was evaluated after a high number of passages (18 for CF-PAEC and 14 for PAEC) by PCR using the following primers: forward, 5′-GACTCAGGGCATGAAACA GG-3′; reverse, 5′-ACTGAGGGGCCTGAAATGA-3′. The 61 bp PCR product was visualized by agarose (3%) gel electrophoresis (Figure 6a ). Cells were then sorted using an anti-CD31 antibody to obtain pure EC (Figure 6b ). The population purity was rechecked after sorting using flow cytometry. As reported in Figure 6c Step 1
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Evaluation of CFTR Expression and Function in Immortalized PAEC
We also evaluated CFTR expression and activity in the immortalized cells. Consistent with results with parental cells (Totani et al, unpublished data), immortalized CF-PAEC exhibited reduced membrane CFTR expression compared to PAEC (Figure 7a ). This was associated with lower CFTR activity compared to non-CF cells (Figure 7b Recent results, also from our group, are challenging the epithelium-centered vision of CF pathogenesis, as CFTR is expressed by a variety of cell types, where it controls a number of relevant functions. Among these, vascular endothelial cells, which are dysfunctional in CF. 10, 11, 22 Despite their potential pathogenetic role in CF, CF-PAEC had never been isolated before. Here we report a simple, inexpensive, and reliable procedure to obtain a virtually pure population of EC from pulmonary arteries of CF patients. To achieve this goal, we had to overcome two main technical problems: the high bacterial contamination of the surgical specimens, due to chronic CF lung infection 23 and the presence of abundant non-endothelial cells among those collected after collagenase digestion of the PA fragments (Figure 2) . A variable number of these cells expressed the CD146 + /CD31 − phenotype (Figures 2 and 4) . They also expressed CD44, CD13, CD73, CD105, CD166, and CD29 ( Figure 1 ), which is consistent with a mesenchymal stem cell phenotype. 24 It has been reported that, when cultured under endothelial conditions, mesenchymal stem cells could differentiate into endothelial cells. 25, 26 Although this may explain the spontaneous enrichment in CD31 + /CD146 + even in populations not subjected to the selection procedure (Figure 4) , further studies are required to fully elucidate this point.
Our method, based on the shorter adhesion time of EC compared to other cell types present in the mixture collected after collagenase digestion of PA (Figures 2, 3 and 4) , is rather simple, but it has some caveats, which may influence its outcome. For instance, seeding density after each selection step is relevant, as low density (∼10%) (Figure 2 ) is more favorable to the identification of EC islands and reduces the number of passages to obtain a good number of pure EC. This is a key issue in experiments with primary cells, particularly EC, which maintain the original phenotype for a limited number of subculturing cycles (www.atcc.org). On the other side, the adhesion time of EC under optimal culturing conditions should not exceed 10 min. Light microscopy monitoring during the procedure is always advised.
We applied our method, first tested with numerous non-CF samples, to two isolates of CF-PAEC from patients with different genotype. In both cases, we observed a great enrichment in EC, obtaining a virtually pure EC population within three passages. In addition of carrying a typical endothelial phenotype (Figures 3 and 4) , these cells generated tubular structures when grown in a matrigel matrix ( Figure 5 ), this confirming their endothelial nature. Compared to cell sorting, which is the preferable strategy to obtain pure cell populations, the present method has the advantage of higher yields as ∼ 50% of cells from one of the CF isolates was lost during sorting (results not shown), and reduced costs and risk of contamination. These features are particularly relevant in the case of CF-PAEC, which are difficult to obtain Figure 6 Immortalization of PAEC and F508del/F508del CF-PAEC. Cells and were infected with SV40LT and selected for puromycin resistance. SV40 gene expression was evaluated after a high number of passages (18 for CF-PAEC and 14 for PAEC) by PCR. The PCR product (61 bp) was visualized by electrophoresis on a 3% agarose gel (a). Both CF-PAEC and PAEC were then sorted using an anti-CD31 antibody and analyzed, at passage 22 for CF-PAEC and 24 for PAEC, by light microscopy (b) and flow cytometry (CD31-FITC/CD 146-PE staining) (c).
Cystic fibrosis endothelial cells R Plebani et al from transplant centers and are at high risk of bacterial colonization. Along these lines, the preparation of immortalized CF-PAEC ( Figure 6 ) may help to overcome the limitation of primary EC cultures, providing a valuable tool to investigators from different fields. Indeed, these cells recapitulated the phenotype of the parental cells, being CFTR membrane expression and activity reduced in CF cells ( Figure 7 ). This is consistent with patch clamping measurements in primary PAEC and CF-PAEC reported in a recently submitted manuscript (Totani et al, unpublished results). In that work, we also extensively characterized the mechanisms of endothelial dysfunction in CF. Here we report that similarly to parental cells, the immortalized CF-PAEC cells displayed reduced TEER compared to PAEC (Figure 7 ). This is consistent with our data (Totani et al, unpublished) and previous studies 11 to sustain CF inflammation, in addition of representing a cardiovascular risk factor. Indeed, microvascular dysfunction has been reported in CF patients, 27 which in association with inflammation, oxidant stress, and extension of the life expectancy, may increase the cardiovascular risk for CF patients. To study these phenomena, an adequate supply of endothelial cells from CF patients, preferably representative of the different class of CFTR mutations, is indispensable. These cells are difficult to obtain, since they can only derive from explanted organs. Moreover, primary endothelial cells have a very limited life span, in vitro, limiting their experimental usability. Thus, a collection of immortalized CF endothelial cells with different genotype may represent, similarly to CF respiratory cells lines, 28 a valuable tool for studies on mechanisms and processes of pathogenetic relevance in CF. As a conclusion, we report here a simple, fast, and highly efficient and reproducible methodology to obtain virtually pure EC populations from surgical specimens. This methodology that can be used to isolate EC from other sources, enabled us to obtain for the first time pure EC from CF patients. These cells can be now used for in vitro studies aimed to a better understanding of CF pathogenetic mechanisms as well as to drug discovery and personalized medicine.
